Reassessing antibiotic dosage and type and restoring gut biome could improve survival rates
Study showed that regimen was well-tolerated in cohort with aggressive carcinoma
Research helps identify patients who might benefit from adjuvant therapies
Analysis suggests association between prior PARP inhibition and subsequent decreased progression-free survival in platinum-sensitive ovarian cancer
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Device provides alternative to conservative management and surgical procedures
Combination improves outcomes without increasing postoperative morbidity
A new study explores survival outcomes based on treatment modality
Study finds 10-month survival difference
Analysis suggests disease outcomes comparable to traditional procedures
Caution warranted when prescribing antibiotics to these patients
Advertisement
Advertisement